abstract |
The present invention relates to a method for the prophylactic and / or therapeutic treatment of diseases and diseases mediated by prostaglandin D 2 , which can be controlled by the inhibition of hematopoietic prostaglandin synthase (H-PGDS) Lt; / RTI > |